Page 530 - IJB-9-6

International Journal of Bioprinting Advances for 3D-printed oral drug delivery systems

74. Tabriz AG, Fullbrook DHG, Vilain L, et al., 2021, 84. Zhang J, Thakkar R, Zhang Y, et al., 2020, Structure-function
Personalised tasted masked chewable 3D printed fruit- correlation and personalized 3D printed tablets using a
chews for paediatric patients. Pharmaceutics, 13(8): 1301. quality (QbD) approach Int J Pharm, 590(2020): 119945.
http://dx.doi.org/10.3390/pharmaceutics13081301 https://doi.org/10.1016/j.ijpharm.2020.119945
75. Bracken L, Habashy R, McDonough E, et al., 2022, Creating 85. Gueche YA, Sanchez-Ballester NM, Bataille B, et al., 2021,
acceptable tablets 3D (CAT 3D): A feasibility study to A QbD approach for evaluating the effect of selective laser
evaluate the acceptability of 3D printed tablets in children sintering parameters on printability and properties of solid
and young people. Pharmaceutics, 14(3): 516. oral forms. Pharmaceutics, 13(10): 1701.
http://dx.doi.org/10.3390/pharmaceutics14030516 http://dx.doi.org/10.3390/pharmaceutics13101701
76. Goh O, Goh W, Lim S, et al., 2022, Preferences of healthcare 86. Wang Y, Müllertz A, Rantanen J, 2022, Structured approach
professionals on 3D-printed tablets: A pilot study. for designing drug-loaded solid products by binder jetting
Pharmaceutics, 14(7): 1521. 3D printing. Eur J Pharm Sci, 178(2022): 106280.
http://dx.doi.org/10.3390/pharmaceutics14071521
https://doi.org/https://doi.org/10.1016/j.ejps.2022.106280
77. Rautamo M, Kvarnström K, Sivén M, et al., 2020, Benefits and 87. Crișan AG, Iurian S, Porfire A, et al., 2022, QbD guided
prerequisites associated with the adoption of oral 3D-printed development of immediate release FDM-3D printed tablets
medicines for pediatric patients: A focus group study among with customizable API doses. Int J Pharm, 613(2022): 121411.
healthcare professionals. Pharmaceutics, 12(3): 229.
https://doi.org/10.1016/j.ijpharm.2021.121411
https://doi.org/10.3390/pharmaceutics12030229
88. Trenfield SJ, Goyanes A, Telford R, et al., 2018, 3D printed drug
78. Goyanes A, Scarpa M, Kamlow M, et al., 2017, Patient products: Non-destructive dose verification using a rapid point-
acceptability of 3D printed medicines. Int J Pharm, 530(1– and-shoot approach. Int J Pharm, 549(1–2): 283–292.
2): 71–78.
https://doi.org/10.1016/j.ijpharm.2018.08.002
https://doi.org/10.1016/j.ijpharm.2017.07.064
89. Trenfield SJ, Tan HX, Goyanes A, et al., 2020, Non-
79. Fastø MM, Genina N, Kaae S, et al., 2019, Perceptions, destructive dose verification of two drugs within 3D printed
preferences and acceptability of patient designed 3D printed polyprintlets. Int J Pharm, 577(2020): 119066.
medicine by polypharmacy patients: A pilot study. Int J Clin
Pharm, 41(5): 1290–1298. https://doi.org/10.1016/j.ijpharm.2020.119066
https://doi.org/10.1007/s11096-019-00892-6 90. Gioumouxouzis CI, Katsamenis OL, Fatouros DG, 2020,
X‐ray microfocus computed tomography: A powerful tool
80. Kabeya K, Satoh H, Hori S, et al., 2021, Experimental for structural and functional characterisation of 3D printed
study on patient preferences regarding the shape and size dosage forms. J Microsc, 277(3): 135–139.
of medical tablets and capsules using three-dimensionally
printed plastic model formulations. Patient Prefer Adherence, https://doi.org/10.1111/jmi.12798
15(2021): 863–870. 91. Lima AL, Pires FQ, Hilgert LA, et al., 2022, Oscillatory
https://doi.org/10.2147/PPA.S306582 shear rheology as an in-process control tool for 3D printing
medicines production by fused deposition modeling.
81. Wang Z, Li J, Hong X, et al., 2021, Taste masking study J Manuf Process, 76(2022): 850–862.
based on an electronic tongue: The formulation design of https://doi.org/10.1016/j.jmapro.2022.03.001
3D printed levetiracetam instant-dissolving tablets. Pharm
Res, 38(5): 831–842. 92. Chamberlain R, Mangiorou E, Fischer B, 2022, Introducing
fiber-assisted colorimetric measurements as a quality
https://doi.org/10.1007/s11095-021-03041-9
control tool of hot melt extruded filaments. Pharmaceutics,
82. Desai N, Masen M, Cann P, et al., 2022, Modernising 14(5): 1055.
orodispersible film characterisation to improve palatability http://dx.doi.org/10.3390/pharmaceutics14051055
and acceptability using a toolbox of techniques.
Pharmaceutics, 14(4): 732 93. Silva IA, Lima AL, Gratieri T, et al., 2022, Compatibility and
stability studies involving polymers used in fused deposition
http://dx.doi.org/10.3390/pharmaceutics14040732
modeling 3D printing of medicines. J Pharm Anal, 12(3):
83. European Medicines Agency, 2017, Quality by design, 424–435.
viewed May 25, 2023, https://doi.org/https://doi.org/10.1016/j.jpha.2021.09.010
https://www.ema.europa.eu/en/human-regulatory/ 94. Callede N, Masciotti T, Casettari L, et al., 2022,
research-development/quality-design Development and evaluation of a 3D printing protocol to
produce zolpidem-containing printlets, as compounding

Volume 9 Issue 6 (2023) 522 https://doi.org/10.36922/ijb.1119